Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 904.79 $ 14.50 (1.63 %)    

Tuesday, 25-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 904.61
$ 891.51
$ 0.00 x 0
$ 0.00 x 0
$ 891.51 - $ 909.29
$ 431.12 - $ 909.42
2,829,637
na
817.59B
$ 0.58
$ 133.19
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novo-nordisks-older-generation-weight-loss-drug-saxenda-associated-with-decreased-bone-mass-density-study-shows
Novo Nordisk's Older Generation Weight-Los...
06/25/2024 18:12:26

Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, ra...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

whats-going-on-with-eli-lilly-stock-on-tuesday
What's Going On With Eli Lilly Stock On Tu...
06/25/2024 16:50:29

Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting dru...

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/25/2024 15:04:28

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

lilly-and-openai-collaborate-to-discover-novel-medicines-to-treat-drug-resistant-bacteria
Lilly And OpenAI Collaborate To Discover N...
06/25/2024 14:01:39

Eli Lilly and Company (NYSE:LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's generativ...

this-is-what-whales-are-betting-on-eli-lilly-and-co
This Is What Whales Are Betting On Eli Lil...
06/25/2024 13:48:07

truist-securities-reiterates-buy-on-eli-lilly-and-co-raises-price-target-to-1000
Truist Securities Reiterates Buy on Eli Li...
06/25/2024 13:12:07

Truist Securities analyst Srikripa Devarakonda reiterates Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target...

whats-going-on-with-eli-lilly-shares-monday
What's Going On With Eli Lilly Shares Monday?
06/24/2024 20:18:06

Eli Lilly and Co (NYSE: LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its we...

why-resmed-shares-are-trading-lower-monday
Why ResMed Shares Are Trading Lower Monday
06/24/2024 18:33:17

ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatmen...

jefferies-maintains-buy-on-eli-lilly-and-co-raises-price-target-to-1015
Jefferies Maintains Buy on Eli Lilly and C...
06/24/2024 18:24:07

Jefferies analyst Akash Tewari maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $994 to $1015.

will-novo-nordisk-building-fires-serve-as-a-catalyst-for-eli-lilly-redditors-see-a-stock-split-for-us-company-very-likely
Will Novo Nordisk Building Fires Serve As ...
06/24/2024 18:08:51

Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/24/2024 17:35:23

b-of-a-securities-maintains-buy-on-eli-lilly-and-co-maintains-1000-price-target
B of A Securities Maintains Buy on Eli Lil...
06/24/2024 16:44:41

B of A Securities analyst Geoff Meacham maintains Eli Lilly and Co (NYSE:LLY) with a Buy and maintains $1000 price target.

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/24/2024 14:46:09

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

eli-lillys-zepbound-for-weight-loss-shows-disease-resolution-in-obese-sleep-apnea-patients-lays-further-groundwork-for-label-expansion
Eli Lilly's Zepbound For Weight Loss Shows...
06/24/2024 12:29:43

Eli Lilly's phase 3 SURMOUNT-OSA trials show tirzepatide injection significantly reduces apnea events in adults with obesit...

eli-lilly-announces-results-from-surmount-osa-phase-3-trials-evaluating-tirzepatide-for-moderate-to-severe-obstructive-sleep-apnea-in-adults-with-obesity-achieves-all-primary-and-key-secondary-endpoints-including-up-to-628-reduction-in-apnea-hypopnea-index
Eli Lilly Announces Results From SURMOUNT-...
06/21/2024 19:51:13

In the primary endpoint, tirzepatide reduced moderate-to-severe OSA severity by up to 62.8% (about 30 fewer events per hour)In ...

Core News & Articles
'House panel weighs new plan for Medicare ...
06/21/2024 18:42:14

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

gilead-sciences-faces-wall-street-speculation-about-obesity-drugs-despite-focus-on-liver-treatments
Gilead Sciences Faces Wall Street Speculat...
06/21/2024 15:42:22

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatme...

move-aside-ozempic-wegovy-denmarks-new-drug-just-showed-positive-results-for-weightloss
Move Aside Ozempic, WeGovy: Denmark's New ...
06/21/2024 12:12:28

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the dr...

nestle-carefully-targets-weight-loss-drug-users-with-new-food-line
Nestle Carefully Targets Weight-Loss Drug ...
06/21/2024 10:18:15

Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)